AeroLEF: Phase IIb data

Data from the open-label portion of the Phase IIb DLXLEF-AP4 trial in 21 patients showed that self-titrated dosing with inhaled AeroLEF was well tolerated. AeroLEF provided "clinically meaningful" ana...